AXGN Q4 2019 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M+20.2% YoY

Gross Profit

$23M82.7% margin

Operating Income

-$7M-26.3% margin

Net Income

-$7M-25.0% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

-1.4%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$155M

Total Liabilities

$22M

Stockholders' Equity

$132M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$23M	+20.2%
Gross Profit	$23M	$20M	+17.6%
Operating Income	-$7M	-$6M	-26.7%
Net Income	-$7M	-$5M	-34.6%